<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01990976</url>
  </required_header>
  <id_info>
    <org_study_id>1208050</org_study_id>
    <secondary_id>2012-A00430-43</secondary_id>
    <nct_id>NCT01990976</nct_id>
  </id_info>
  <brief_title>Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.</brief_title>
  <acronym>FSHD3</acronym>
  <official_title>Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Association Française contre les Myopathies (AFM), Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The safety of guided practice of physical activity in myopathies is increasingly accepted,&#xD;
      including muscular dystrophies. In facioscapulohumeral dystrophy (FSHD), one of the most&#xD;
      common muscular dystrophy, the aerobic training showed its physiological and functional&#xD;
      efficiency without affecting the quality of life of patients. The issue of exercise therapy&#xD;
      extended to all neuromuscular diseases, as has been rigorously analyzed, shows that the use&#xD;
      of a training program combining endurance exercise targeted exercises and strength is even&#xD;
      more relevant.&#xD;
&#xD;
      To complete the multidimensional assessments be managed by each team ( physiological&#xD;
      assessments, functional tissue and quality of life) it is relevant to continue , for a&#xD;
      descriptive study quantitative and qualitative analyzes by muscle imaging and spectroscopy&#xD;
      (MRI and Nuclear Resonance Imaging (NMR) spectroscopy ).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      These non-invasive assessments already in place at the time of the initial training (FSHD1&#xD;
      study, NCT01116570) will be repeated in the medium (12 months) and long term (30 months) in&#xD;
      the same laboratory NMR AIM - CEA , Institute of Myology in Paris (P Carlier ). The data&#xD;
      obtained from NMR repeated examinations and those obtained from biochemical analyzes and&#xD;
      additional muscle histomorphometric (cellular aging estimation of involution fibroadipose )&#xD;
      on biopsies already programmed (initial, 6 months and 30 months, FSHD2 study, NCT01689480)&#xD;
      will be respectively compared to initial time to follow the evolution food and energy&#xD;
      capacity of trained muscles. The study of biopsies provide mechanistic arguments and&#xD;
      morphometric specific cellular response to exercise, data will be advantageously complemented&#xD;
      by NMR specialized examinations extended to all the muscles of the thigh (target of training&#xD;
      ) and muscle quantification whole body MRI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Parameters of MRI</measure>
    <time_frame>30 months</time_frame>
    <description>whole body imaging T1, T2-weighted</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle tissue parameters</measure>
    <time_frame>30 months</time_frame>
    <description>muscle biopsy</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Muscular Dystrophy</condition>
  <condition>Facioscapulohumeral</condition>
  <arm_group>
    <arm_group_label>FSHD training</arm_group_label>
    <description>Only the patients who have participated to the FSHD1 study (NCT01116570) and the FSHD2 study (NCT01689480) can be included in this study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>In Paris centre, a total body NMR imaging will be done with standard T2- and T1-weighted images.</description>
    <arm_group_label>FSHD training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biopsy</intervention_name>
    <description>biopsy of the vastus lateralis muscle</description>
    <arm_group_label>FSHD training</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Muscles&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with facioscapulohumeral dystrophy and who have participated to the FSHD1 and FSHD2&#xD;
        studies&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Included in the FSHD1 and FSHD2 studies&#xD;
&#xD;
          -  Social Security regimen affiliated&#xD;
&#xD;
          -  Consent form signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiac or respiratory insufficiency&#xD;
&#xD;
          -  Cardiac pacemaker&#xD;
&#xD;
          -  Morbid obesity (BMI upper to 35)&#xD;
&#xD;
          -  Anti platelet therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Léonard FEASSON, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Saint-Etienne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Grenbole</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Saint-Etienne</name>
      <address>
        <city>St Etienne</city>
        <zip>42000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <study_first_submitted>November 18, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Muscular Dystrophy</keyword>
  <keyword>Facioscapulohumeral</keyword>
  <keyword>Physical training</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Muscle Biopsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Muscular Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

